Paolo Denti (P Denti)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 103

Top Venues

Antimicrobial agents and chemotherapy

American journal of respiratory and critical care medicine

The Journal of antimicrobial chemotherapy

British journal of clinical pharmacology

University of Cape Town

Università degli Studi di Padova (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cape Town

South Africa

Researcher :: Division of Clinical Pharmacology

Education History

Università degli Studi di Padova

Italy

PHD :: Dipartimento di Elettronica e Informatica

Publications

Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Manna Semere Gebreyesus, Alexandra Dresner, Lubbe Wiesner, Ettienne Coetzee, Tess Verschuuren, Roeland E Wasmann, Paolo Denti
Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass. CPT: pharmacometrics & systems pharmacology (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Jill M Combrinck, Phophi Tshavhungwe, Ursula K Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen Mcilleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley, null null
High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial. American journal of respiratory and critical care medicine (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley, null null
High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial. American journal of respiratory and critical care medicine (2024)
Jill M Combrinck, Phophi Tshavhungwe, Ursula K Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen Mcilleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Sean Wasserman, Rosleine Antilus-Sainte, Noha Abdelgawad, Narineh M Odjourian, Melissa Cristaldo, Maureen Dougher, Firat Kaya, Matthew Zimmerman, Paolo Denti, Martin Gengenbacher
Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis. Antimicrobial agents and chemotherapy 68 (8) (2024)
Jill M Combrinck, Phophi Tshavhungwe, Ursula K Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen Mcilleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Lufina Tsirizani Galileya, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, Alexander J Szubert, Veronica Mulenga, Chishala Chabala, Mutsa Bwakura-Dangarembizi, Moses Chitsamatanga, Diana A Rutebarika, Victor Musiime, Mariam Kasozi, Abbas Lugemwa, Lara N Monkiewicz, Helen M McIlleron, David M Burger, Diana M Gibb, Paolo Denti, Roeland E Wasmann, Angela Colbers
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV. The Journal of antimicrobial chemotherapy (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine (2024)
Sean Wasserman, Rosleine Antilus-Sainte, Noha Abdelgawad, Narineh M Odjourian, Melissa Cristaldo, Maureen Dougher, Firat Kaya, Matthew Zimmerman, Paolo Denti, Martin Gengenbacher
Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis. Antimicrobial agents and chemotherapy (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta, Sarah E Weber, Richard Court, Bronwyn Myers, Tara Carney, Charles D H Parry, Charles R Horsburgh, Laura F White, Lubbe Wiesner, Robin M Warren, Caitlin Uren, Helen M McIlleron, Frank Kloprogge, Paolo Denti, Karen R Jacobson
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. The Journal of antimicrobial chemotherapy (2024)
Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta, Sarah E Weber, Richard Court, Bronwyn Myers, Tara Carney, Charles D H Parry, Charles R Horsburgh, Laura F White, Lubbe Wiesner, Robin M Warren, Caitlin Uren, Helen M McIlleron, Frank Kloprogge, Paolo Denti, Karen R Jacobson
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Sean Wasserman, Rosleine Antilus-Sainte, Noha Abdelgawad, Narineh M Odjourian, Melissa Cristaldo, Maureen Dougher, Firat Kaya, Matthew Zimmerman, Paolo Denti, Martin Gengenbacher
Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis. Antimicrobial agents and chemotherapy 68 (8) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Manna Semere Gebreyesus, Roeland E Wasmann, Helen M McIlleron, Regina Oladokun, Prosper Okonkwo, Lubbe Wiesner, Paolo Denti, Holly E Rawizza
Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy. Antimicrobial agents and chemotherapy 68 (8) (2024)
Manna Semere Gebreyesus, Roeland E Wasmann, Helen M McIlleron, Regina Oladokun, Prosper Okonkwo, Lubbe Wiesner, Paolo Denti, Holly E Rawizza
Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy. Antimicrobial agents and chemotherapy (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley, null null
High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial. American journal of respiratory and critical care medicine (2024)
Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Diana Gibb, Helen M McIlleron, Angela Colbers, David Burger, Paolo Denti, null null
Population pharmacokinetics of Dolutegravir in African Children: results from the CHAPAS-4 trial. Journal of the Pediatric Infectious Diseases Society (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Sean Wasserman, Rosleine Antilus-Sainte, Noha Abdelgawad, Narineh M Odjourian, Melissa Cristaldo, Maureen Dougher, Firat Kaya, Matthew Zimmerman, Paolo Denti, Martin Gengenbacher
Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis. Antimicrobial agents and chemotherapy 68 (8) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology (2024)
Manna Semere Gebreyesus, Roeland E Wasmann, Helen M McIlleron, Regina Oladokun, Prosper Okonkwo, Lubbe Wiesner, Paolo Denti, Holly E Rawizza
Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy. Antimicrobial agents and chemotherapy 68 (8) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. American journal of respiratory and critical care medicine 210 (3) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy (2024)
Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta, Sarah E Weber, Richard Court, Bronwyn Myers, Tara Carney, Charles D H Parry, Charles R Horsburgh, Laura F White, Lubbe Wiesner, Robin M Warren, Caitlin Uren, Helen M McIlleron, Frank Kloprogge, Paolo Denti, Karen R Jacobson
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Manna Semere Gebreyesus, Roeland E Wasmann, Helen M McIlleron, Regina Oladokun, Prosper Okonkwo, Lubbe Wiesner, Paolo Denti, Holly E Rawizza
Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy. Antimicrobial agents and chemotherapy 68 (8) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim, Ashley McKhann, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Philip Marzinek, Naadira Vanker, Joseph Yvetot, Samuel Pierre, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Paolo Denti, Kelly E Dooley, null null
High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial. American journal of respiratory and critical care medicine (2024)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Noha Abdelgawad, Sean Wasserman, Mahmoud Tareq Abdelwahab, Angharad Davis, Cari Stek, Lubbe Wiesner, John Black, Graeme Meintjes, Robert J Wilkinson, Paolo Denti
Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis. The Journal of infectious diseases (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy 67 (3) (2023)
Kamunkhwala Gausi, Henry Mugerwa, Marco Siccardi, Maiara Camotti Montanha, Mohammed Lamorde, Lubbe Wiesner, Antonio D'Avolio, Helen McIlleron, Ed Wilkins, Amedeo De Nicolò, Gary Maartens, Saye Khoo, Cissy Kityo, Paolo Denti, Catriona Waitt
Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy 67 (3) (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy 67 (3) (2023)
Louvina E van der Laan, Anneke C Hesseling, Pawel T Schubert, Megan Palmer, Heather R Draper, Lubbe Wiesner, Paolo Denti, Anthony J Garcia-Prats
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children. The Journal of antimicrobial chemotherapy (2023)
Lufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, Helena Rabie, Janice Lee, Irene N Mukui, Anneke Hesseling, Heather J Zar, Rob Aarnoutse, Anna Turkova, Diana M Gibb, Mark Fredric Cotton, Helen M McIlleron, Paolo Denti
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. PLoS medicine 20 (11) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy (2023)
Robin Michelet, Linda B S Aulin, Jens Markus Borghardt, Teresa Dalla Costa, Paolo Denti, Manuel Ibarra, Guangda Ma, Bernd Meibohm, Goonaseelan Colin Pillai, Stephan Schmidt, Stefanie Hennig, Charlotte Kloft
Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT: pharmacometrics & systems pharmacology (2023)
Noha Abdelgawad, Mvuwo Phophi Tshavhungwe, Ursula Rohlwink, Helen M McIlleron, Mahmoud T Abdelwahab, Lubbe Wiesner, Sandra Castel, Chanel Steele, Johannes Nico Enslin, Nqobile Sindiswa Thango, Paolo Denti, Anthony Figaji
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis. Antimicrobial agents and chemotherapy 67 (3) (2023)
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, Lubbe Wiesner, Chishala Chabala, Mutsa Bwakura-Dangarembizi, Shafic Makumbi, Joan Nangiya, Vivian Mumbiro, Veronica Mulenga, Victor Musiime, Lara N Monkiewicz, Anna L Griffiths, Alasdair Bamford, Katja Doerholt, Paolo Denti, David M Burger, Diana M Gibb, Helen M McIlleron, Angela Colbers, null null
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Louvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, Maxwell Chirehwa, Jana L Winckler, Jun Mao, Heather R Draper, Lubbe Wiesner, Jennifer Norman, Helen M McIlleron, Peter R Donald, Anneke C Hesseling, Paolo Denti
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis". Antimicrobial agents and chemotherapy (2023)
Jill M Combrinck, Phophi Tshavhungwe, Ursula K Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen Mcilleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis. The Journal of antimicrobial chemotherapy (2023)
Noha Abdelgawad, Sean Wasserman, Mahmoud Tareq Abdelwahab, Angharad G Davis, Cari Stek, Lubbe Wiesner, John Black, Graeme Meintjes, Robert John Wilkinson, Paolo Denti
Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis. medRxiv : the preprint server for health sciences (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy (2023)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Phumla Z Sinxadi, Simiso Mandisa Sokhela, Nomathemba C Chandiwana, Willem Daniel Francois Venter, Lubbe Wiesner, Gary Maartens, Paolo Denti
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population. CPT: pharmacometrics & systems pharmacology (2023)
Louvina E van der Laan, Anthony J Garcia-Prats, Helen M McIlleron, Mahmoud Tareq Abdelwahab, Jana L Winckler, Heather R Draper, Lubbe Wiesner, H Simon Schaaf, Anneke C Hesseling, Paolo Denti
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy (2023)
Allan Kengo, Ruth Nabisere, Kamunkhwala Gausi, Joseph Musaazi, Allan Buzibye, Denis Omali, Rob Aarnoutse, Mohammed Lamorde, Kelly E Dooley, Derek James Sloan, Paolo Denti, Christine Sekaggya-Wiltshire
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial agents and chemotherapy (2023)
Angharad G Davis, Sean Wasserman, Cari Stek, Mpumi Maxebengula, C Jason Liang, Stephani Stegmann, Sonya Koekemoer, Amanda Jackson, Yakub Kadernani, Marise Bremer, Remy Daroowala, Saalikha Aziz, Rene Goliath, Louise Lai Sai, Thandi Sihoyiya, Paolo Denti, Rachel Pj Lai, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Ismail Abbas Banderker, Muhammed S Moosa, Peter Raubenheimer, Sally Candy, Curtis Offiah, Gerda Wahl, Isak Vorster, Gary Maartens, John Black, Graeme Meintjes, Robert J Wilkinson
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Zinhle Cindi, Aida N Kawuma, Gary Maartens, Yuki Bradford, Francois Venter, Simiso Sokhela, Nomathemba Chandiwana, Roeland E Wasmann, Paolo Denti, Lubbe Wiesner, Marylyn D Ritchie, David W Haas, Phumla Z Sinxadi
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus. The Journal of infectious diseases 226 (9) (2022)
Tjokosela Tikiso, Helen McIlleron, Mahmoud Tareq Abdelwahab, Adrie Bekker, Anneke Hesseling, Chishala Chabala, Geraint Davies, Heather J Zar, Helena Rabie, Isabelle Andrieux-Meyer, Janice Lee, Lubbe Wiesner, Mark F Cotton, Paolo Denti
Population pharmacokinetics of ethambutol in African children: a pooled analysis. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Ali Mohamed Ali, Kamunkhwala Gausi, Said A Jongo, Kamaka R Kassim, Catherine Mkindi, Beatus Simon, Ali T Mtoro, Omar A Juma, Omar N Lweno, Conrad H Gwandu, Bakari M Bakari, Thabiti A Mbaga, Florence A Milando, Ali Hamad, Seif A Shekalaghe, Salim Abdulla, Paolo Denti, Melissa A Penny
Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization. Antimicrobial agents and chemotherapy 66 (5) (2022)
Rulan Griesel, Aida N Kawuma, Roeland E Wasmann, Simiso Sokhela, Godspower Akpomiemie, W D Francois Venter, Lubbe Wiesner, Paolo Denti, Phumla Sinxadi, Gary Maartens
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy. British journal of clinical pharmacology 88 (3) (2022)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Kelly E Dooley, Marta Boffito, Gary Maartens, Paolo Denti
Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with Rifampicin. Antimicrobial agents and chemotherapy 66 (6) (2022)
Christine Sekaggya-Wiltshire, Ruth Nabisere, Joseph Musaazi, Brian Otaalo, Florence Aber, Lucy Alinaitwe, Juliet Nampala, Letisha Najjemba, Allan Buzibye, Denis Omali, Kamunkhwala Gausi, Allan Kengo, Mohammed Lamorde, Rob Aarnoutse, Paolo Denti, Kelly E Dooley, Derek J Sloan
Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with TB and HIV receiving high-dose rifampicin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Sara N Salerno, Edmund V Capparelli, Helen M McIlleron, Jacqueline G Gerhart, Julie B Dumond, Angela D M Kashuba, Paolo Denti, Daniel Gonzalez
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients. Pharmacotherapy (2022)
David W Haas, Mahmoud Tareq Abdelwahab, Stijn W van Beek, Paxton Baker, Gary Maartens, Yuki Bradford, Marylyn D Ritchie, Sean Wasserman, Graeme Meintjes, Karen Beeri, Neel R Gandhi, Elin M Svensson, Paolo Denti, James C M Brust
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa. The Journal of infectious diseases 226 (1) (2022)
Louvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, Maxwell Tawanda Chirehwa, Jana L Winckler, Jun Mao, Heather R Draper, Lubbe Wiesner, Jennifer Norman, Helen M McIlleron, Peter R Donald, Anneke C Hesseling, Paolo Denti
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 66 (6) (2022)
Manna Semere Gebreyesus, Eric H Decloedt, Catherine Anne Cluver, Nicole Geertruida Maria Hunfeld, Hólmfríður Helgadóttir, Einar Stefan Björnsson, Roeland E Wasmann, Paolo Denti
Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia. British journal of clinical pharmacology 88 (10) (2022)
Richard Court, Kamunkhwala Gausi, Buyisile Mkhize, Lubbe Wiesner, Catriona Waitt, Helen M McIlleron, Gary Maartens, Paolo Denti, Marian Loveday
Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis. British journal of clinical pharmacology 88 (8) (2022)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Kelly E Dooley, Gary Maartens, Paolo Denti
Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model. British journal of clinical pharmacology (2022)
Rulan Griesel, Phumla Sinxadi, Aida Kawuma, John Joska, Simiso Mandisa Sokhela, Godspower Akpomiemie, Willem Daniel Francois Venter, Paolo Denti, David W Haas, Gary Maartens
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Kamunkhwala Gausi, Maxwell Tawanda Chirehwa, Elisa H Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L Rosenkranz, Veronique de Jager, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Susan Swindells, Andreas Diacon, Kelly E Dooley, Helen McIlleron, Paolo Denti
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Elisa H Ignatius, Mahmoud Tareq Abdelwahab, Bronwyn Hendricks, Nikhil Gupte, Kim Narunsky, Lubbe Wiesner, Grace Barnes, Rodney Dawson, Kelly E Dooley, Paolo Denti
Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis. Antimicrobial agents and chemotherapy 65 (2) (2021)
Precious Ngwalero, James C M Brust, Stijn W van Beek, Sean Wasserman, Gary Maartens, Graeme Meintjes, Anton Joubert, Jennifer Norman, Sandra Castel, Neel R Gandhi, Paolo Denti, Helen M McIlleron, Elin M Svensson, Lubbe Wiesner
Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 65 (11) (2021)
Mahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, Keertan Dheda, Lubbe Wiesner, Neel R Gandhi, Robin M Warren, Frederick A Sirgel, Graeme Meintjes, Gary Maartens, Paolo Denti
Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 65 (12) (2021)
Paolo Denti, Roeland E Wasmann, Annelies van Rie, Jana Winckler, Adrie Bekker, Helena Rabie, Anneke C Hesseling, Louvina E van der Laan, Carmen Gonzalez-Martinez, Heather J Zar, Gerry Davies, Lubbe Wiesner, Elin M Svensson, Helen M McIlleron
Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Tjokosela Tikiso, Helen McIlleron, David Marinus Burger, Diana Gibb, Helena Rabie, Janice Lee, Marc Lallemant, Mark F Cotton, Moherndran Archary, Stefanie Hennig, Paolo Denti
Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications. British journal of clinical pharmacology (2021)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy 65 (10) (2021)
Kamunkhwala Gausi, Elisa H Ignatius, Xin Sun, Soyeon Kim, Laura Moran, Lubbe Wiesner, Florian von Groote-Bidlingmaier, Richard Hafner, Kathleen Donahue, Naadira Vanker, Susan L Rosenkranz, Susan Swindells, Andreas H Diacon, Eric L Nuermberger, Kelly E Dooley, Paolo Denti
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial. American journal of respiratory and critical care medicine 204 (11) (2021)
Roeland E Wasmann, Elin M Svenson, Ann Sarah Walker, Michelle N Clements, Paolo Denti
Constructing a representative in-silico population for paediatric simulations: Application to HIV-positive African children. British journal of clinical pharmacology 87 (7) (2021)
Helena Rabie, Tjokosela Tikiso, Janice Lee, Lee Fairlie, Renate Strehlau, Raziya Bobat, Afaaf Liberty, Helen McIlleron, Isabelle Andrieux-Meyer, Mark Cotton, Marc Lallemant, Paolo Denti
Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir. Antimicrobial agents and chemotherapy 64 (5) (2020)
Jose Francis, Karen I Barnes, Lesley Workman, Tamara Kredo, Lasse S Vestergaard, Richard M Hoglund, Pauline Byakika-Kibwika, Mohammed Lamorde, Stephen I Walimbwa, Ifeyinwa Chijioke-Nwauche, Colin J Sutherland, Concepta Merry, Kimberley K Scarsi, Nyagonde Nyagonde, Martha M Lemnge, Saye H Khoo, Ib C Bygbjerg, Sunil Parikh, Francesca T Aweeka, Joel Tarning, Paolo Denti
An Individual Participant Data Population Pharmacokinetic Meta-analysis of Drug-Drug Interactions between Lumefantrine and Commonly Used Antiretroviral Treatment. Antimicrobial agents and chemotherapy 64 (5) (2020)
Mahmoud Tareq Abdelwahab, Rory Leisegang, Kelly E Dooley, Jyoti S Mathad, Lubbe Wiesner, Helen McIlleron, Neil Martinson, Ziyaad Waja, Matebogo Letutu, Richard E Chaisson, Paolo Denti
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV. Antimicrobial agents and chemotherapy 64 (3) (2020)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone. Antimicrobial agents and chemotherapy 64 (11) (2020)
Henrik B Nyberg, Heather R Draper, Anthony J Garcia-Prats, Stephanie Thee, Adrie Bekker, Heather J Zar, Andrew C Hooker, H Simon Schaaf, Helen McIlleron, Anneke C Hesseling, Paolo Denti
Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis. Antimicrobial agents and chemotherapy 64 (3) (2020)
Jose Francis, Simbarashe P Zvada, Paolo Denti, Mark Hatherill, Salome Charalambous, Stanley Mungofa, Rodney Dawson, Susan Dorman, Nikhil Gupte, Lubbe Wiesner, Amina Jindani, Thomas S Harrison, Adeniyi Olagunju, Deirdre Egan, Andrew Owen, Helen M McIlleron
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrobial agents and chemotherapy 63 (4) (2019)
Christine Sekaggya-Wiltshire, Maxwell Chirehwa, Joseph Musaazi, Amrei von Braun, Allan Buzibye, Daniel Muller, Ursula Gutteck, Ilaria Motta, Andrea Calcagno, Jan S Fehr, Andrew Kambugu, Barbara Castelnuovo, Mohammed Lamorde, Paolo Denti
Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines? Antimicrobial agents and chemotherapy 63 (6) (2019)

Paolo Denti.css-eqlu8i{font-size:small;padding-left:4px;} (P Denti)

Publication Activity (10 Years)

Top Topics

Top Venues

Paolo Denti (P Denti)